Skip to search.
 FTSE 100 Up 0.42%
Streaming
Ticker Tape: On

Theravance Inc. (THRX)

-NasdaqGS
26.76 Down 0.31(1.15%) 17:15 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:27.07
Open:27.12
Bid:26.81 x 200
Ask:26.86 x 100
1y Target Est:41.29
Beta:0.68
Next Earnings Date: 6-May-14THRX Earnings announcement
Day's Range:26.38 - 27.72
52wk Range:26.04 - 42.96
Volume:389,672
Avg Vol (3m):1,001,150
Market Cap:3.00b
P/E (ttm):N/A
EPS (ttm):-1.67
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
THRXDown 1.15%3.00b
AZNUp 3.25%87.98b
CBSTUp 0.74%5.00b
PFEDown 0.76%195.87b

Key Statistics

Forward P/E (1 yr):127.71
P/S (ttm):637.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.29
Quarterly EPS Est (Mar-14) :-0.53
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Theravance, Inc., a biopharmaceutical company, is engaged in the discovery, development, and commercialization of small molecule medicines primarily for therapeutic areas of respiratory diseases, bacterial infections, and central nervous system/pain. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback